Limited Access
Please log in to myERS to view this content
Don't have a myERS account? Register here
Note: patients and members of the public are not permitted to view this content
Sanofi
This content has been provided by Sanofi Regeneron. The content is not influenced or endorsed by the European Respiratory Society
Type 2 inflammation contributes to immune cell trafficking, barrier dysfunction, and neuroimmune dysregulation. Learn more about the pathophysiology of type 2 inflammatory diseases here